Inflammatory Bowel Disease Market Growth, Trends & Forecast 2025 | Top key players - Pfizer Inc, Biogen, Novartis AG.

The latest report published by DataM Intelligence highlights the growth prospects of Inflammatory Bowel Disease market. The industry expansion is majorly driven by developments in technology across the globe.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/inflammatory-bowel-disease-market?sz

The Global Inflammatory Bowel Disease Market reached USD 19 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 26.7 billion by 2031. The global inflammatory bowel disease market is expected to exhibit a CAGR of 4.4% during the forecast period 2024-2031.

Inflammatory Bowel Disease (IBD) refers to chronic conditions like Crohn's disease and ulcerative colitis, where the digestive tract becomes inflamed. This market encompasses treatments such as medications, biologics, and surgical options to manage symptoms and improve quality of life. Rising prevalence and advancements in therapies drive market growth, creating opportunities for pharmaceutical companies and healthcare providers.

Competitive Evaluation:

Companies covered in this report are AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Eli Lilly Company, Merck & Co., Inc., Johnson & Johnson, Biocon Ltd., and Sanofi among Others.

The Inflammatory Bowel Disease Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.

Key Development

On March 16, 2022, AbbVie announced that the U.S. Food and Drug Administration (FDA) had approved RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active ulcerative colitis (UC) who have not responded adequately or have shown intolerance to one or more tumor necrosis factor (TNF) blockers.

On February 27, 2023, AbbVie revealed its plan to present additional analyses on SKYRIZI (risankizumab) in Crohn's disease (CD) and RINVOQ (upadacitinib) in ulcerative colitis (UC). The company will also present data on the investigational use of upadacitinib in Crohn's disease (CD) at the 18th Congress of the European Crohn's and Colitis Organisation (ECCO), scheduled to take place from March 1-4 in Copenhagen, Denmark.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/inflammatory-bowel-disease-market

Inflammatory Bowel Disease Market Segments

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Type: Crohn's Disease, Ulcerative colitis.

By Route of Administration: Oral Route, Rectal Route, Subcutaneous Route, Intravenous Route.

By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Assessment:

Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Inflammatory Bowel Disease market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

In terms of geographical analysis, Inflammatory Bowel Disease Market report provides an in-depth view of:-

∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/inflammatory-bowel-disease-market

This report provides a 360-degree synopsis of the competitive scenario of the Inflammatory Bowel Disease industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports: https://www.datamintelligence.com/research-report/inflammatory-bowel-disease-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.